• 제목/요약/키워드: traditional drug

검색결과 770건 처리시간 0.029초

다양한 발효균주를 이용한 인삼패독산의 생물 전환 성분의 정량 분석 (Quantitative Analysis of Bioconversion Constituents of Insampeadock-san Using Various Fermented Bacteria)

  • 이광진;구민정;노주환;정필문;마진열
    • 약학회지
    • /
    • 제57권3호
    • /
    • pp.167-172
    • /
    • 2013
  • Insampaedoksan (IS) is the decoction of medicinal herbs, which was commonly used for anti-inflammatory and anti-pyretic in the Korean traditional medicine (KTM). Several studies on improving efficiency or searching new efficiency by fermenting traditional herbal medicines are recently in progress. The bioconversion has been conducted on IS using various bacteria. Liquiritin, ferulic acid, hesperidin, liquiritigenin, and glycyrrhizin in IS before and after fermented IS were simultaneously analyzed. These compounds were qualitatively analyzed and quantitatively analyzed using the HPLC-DAD system. The identifications of liquiritin, ferulic acid, hesperidin, liquiritigenin and glycyrrhizin were achieved by comparing the HPLC retention time ($R_t$) and the UV absorption of five pure compounds in the IS. As a result, the increased constituents were identified to be liquiritin, liquiritigenin and glycyrrhizin, while the decreased constituent was ferulic acid and the constituent of hesperidin was similar to before and after fermentation. Insampeadock-san fermented by Lactobacillus plantarum KFRI 144 exhibited the most remarkable changes in all of fermentation.

천웅(天雄)의 포제에 관하여 (Study on The Drug Processing of Aconiti Root(天雄))

  • 최정현;정병하;성만준;권동렬
    • 대한한의학방제학회지
    • /
    • 제12권1호
    • /
    • pp.123-130
    • /
    • 2004
  • Aconiti Root(AR), has been used for about 2000 years, since recorded for low grade in 'Shinnongbonchokyung(Divine Husbandman's Herbal Foundation canon)'. It also recorded for Poisonous Drug in 'Myunguibyullok', 'Yaksungron', etc, and they advised when the AR is using for clinical desease it has to be processed. There are more than 13 processing methods, in records that related 39 parts which is recorded in ancient documents. In China, there are no standard of herb that using for clinical, cause of the traditional processing methods was cut since 1960s. In these days, they are using AR that recorded in Aconiti Tuber part of the processing records, in Guangdong and Shantung. In addition, the modification of Processed Aconiti Root(PAR) is also used for goods in Hongkong, Macao, and Southeast Asia. We studied the PAR for enhancing the importance of it, and multiply using. In this study, we search for the history of processing of AR, traditional theories of processing and clinical adaptation.

  • PDF

뇌출혈 환자의 피부약물 유해반응에 대한 가미승마갈근탕 치험 1례 (A Case Report of Gamiseungmagalgeun-tang for a Cutaneous Adverse Drug Reaction in a Patient with Intracerebral Hemorrhage)

  • 석은주;홍정화;이영주;유재혁;이진영;최동준
    • 대한한방내과학회지
    • /
    • 제45권2호
    • /
    • pp.278-286
    • /
    • 2024
  • A cutaneous adverse drug reaction (CADR) refers to an unexpected skin and mucosal reaction caused by drug administration. In the present case, a 65-year-old male presented with generalized itching and a maculopapular rash after taking Western medication, including anticonvulsants and a nonsteroidal anti-inflammatory drug (NSAID). He was treated with Gamiseungmagalgeun-tang, a traditional Korean herbal medicine. After treatment, the patient's symptoms improved, without recurrence. Based on this experience, traditional Korean herbal medicine, including Gamiseungmagalgeun-tang, may be beneficial for improving symptoms of CADRs.

Effects of Korean traditional herbal formula for common cold on the activities of human CYP450 isozymes

  • Jin, Seong Eun;Ha, Hyekyung;Jeong, Soo-Jin;Shin, Hyeun-Kyoo
    • 대한한의학회지
    • /
    • 제35권2호
    • /
    • pp.47-59
    • /
    • 2014
  • Objectives: Most drug interactions are attributed to the inhibition or induction of the activity of cytochrome P450s (CYP450). Although the regulation of CYP450s by drugs has been widely reported, there have been few studies on influence of traditional herbal formulas on the drug-metabolizing enzymes. Because herbal formulas have been used traditionally to treat various diseases and because herb-drug interactions are crucial factors determining therapeutic efficacies, a systematic evaluation of the effects of herbal formulas is important. Methods: The effects of Galgeun-tang (GGT, gegen tang), Gumiganghwal-tang (GMGHT, jiuweiqianghuo tang), Insampaedok-san (ISPDS, renshenbaidu powder), Samsoeum (SSE, shensu drink), Socheongryong-tang (SCRT, xiaoqinglong-tang) and Sosiho-tang (SSHT, xiaochaihu tang) that are traditional herbal formulas used to treat common cold, on drug-metabolizing enzymes were evaluated through an in vitro CYP3A4, CYP2D6, CYP2C19 and CYP2E1 inhibition assay to assess its interaction potential with synthetic drugs. The inhibitory effects of herbal formulas were characterized with $IC_{50}$ values. Results: These six herbal formulas inhibited the activities of CYP3A4, 2C19, 2D6 and 2E1, in a concentration-dependent manner. Among the six herbal formulas, GGT critically inhibited CYP2C19, CYP2D6 and CYP2E1. GMGHT also inhibited CYP2D6 and CYP2E1 to a greater extent than the other CYP450 isozymes. Additionally, SSE and SSHT may change the effects of medicines that depend primarily on the CYP2C19 and CYP2E1 pathways. On the other hand, ISPDS and SCRT were not inhibited CYP3A4, CYP2C19, CYP2D6 and CYP2E1-mediated metabolism. Conclusions: These findings provide useful information regarding the safety and effectiveness of herbal formulas.

Interpretation of Animal Dose and Human Equivalent Dose for Drug Development

  • Shin, Jang-Woo;Seol, In-Chan;Son, Chang-Gue
    • 대한한의학회지
    • /
    • 제31권3호
    • /
    • pp.1-7
    • /
    • 2010
  • Objectives: To introduce to TKM scientific dose conversion methods of human to animal or animal to human for new drug investigations. Methods: We searched guidelines of the FDA and KFDA, and compared them with references for drug-dose conversion from various databases such as PubMed and Google. Then, we analyzed the potential issues and problems related to dose conversion in safety documentation of new herbal drugs based on our experiences during Investigational New Drug (IND) applications of TKM. Results: Dose conversion from human to animal or animal to human must be appropriately translated during new drug development. From time to time, investigators have some difficulty in determining the appropriate dose, because of misunderstandings of dose conversion, especially when they estimate starting dose in clinical or animal studies to investigate efficacy, toxicology and mechanisms. Therefore, education of appropriate dose calculation is crucial for investigators. The animal dose should not be extrapolated to humans by a simple conversion method based only on body weight, because many studies suggest the normalization method is based mainly on body surface area (BSA). In general, the body surface area seems to have good correlation among species with several parameters including oxygen utilization, caloric expenditure, basal metabolism, blood volume and circulating plasma protein. Likewise, a safety factor should be taken into consideration when deciding high dose in animal toxicology study. Conclusion: Herein, we explain the significance of dose conversion based on body surface area and starting dose estimation for clinical trials with safety factor.

HPLC를 이용한 전통식품 중 오크라톡신 A 오염도 조사 (Survey of Ochratoxin A in Cereal-based Korean Traditional Foods by HPLC)

  • 박성국;권기성;김미혜;정소영;장귀현;남태희;이종옥;김명철
    • 한국식품과학회지
    • /
    • 제36권1호
    • /
    • pp.158-161
    • /
    • 2004
  • 국내 전통식품 중에 함유되어 있는 ochratoxin A를 검출할 수 있는 신속, 정확한 분석방법을 확립하고자 immunoaffinity column과 $C_{18}$ Sep-Pak cartridge를 비교 후 분리도와 회수율이 우수한 immunoaffinity column으로 전처리 방법을 사용하였으며 HPLC 검출한계는 $0.5{\mu}g/kg$로 나타났다. 오염도조사를 위하여 시판되는 장류(고추장, 된장, 간장 각 20건) 60건을 수거하여 분석한 결과 고추장 3건, 된장 2건, 간장 1건에서 $0.5-1.3{\mu}g/kg$ 수준으로 검출되었으며 수거된 선식 40건에서는 ochratoxin A가 검출한계이하 수준이었다. 이는 일부 외국의 규격치인 $5-50{\mu}g/kg$와 비교해 볼 때 낮은 수준이었다.

A Severe Hepatotoxicity by Antituberculosis Drug, and its Recovery in Oriental Hospital

  • Son, Chang-Gue
    • 대한한의학회지
    • /
    • 제37권2호
    • /
    • pp.119-124
    • /
    • 2016
  • Objectives: To demonstrate a clinical course and feature of a female patient with a severe liver injury (DILI) during antituberculosis treatment for her intestinal tuberculosis, whom traditional Korean medicine completely recovered. Methods: A female patient with diagnosed as DILI by antituberculosis drugs had been treated with herbal drugs; and then the clinical outcome and biochemical parameters had been monitored. Result: A 45-year old female had taken antituberculosis drugs for about 2 months, and complained severe abdominal discomfort and dyspepsia. The RUCAM score was 10, which met the criteria for DILI (AST 584 IU/L, ALT 1212 IU/L, ALP 100 IU/L, and GGT 161 IU/L, total bilirubin 0.9 mg/dL). She had been treated with herbal drugs and acupuncture as inpatient and outpatient, and then her symptoms had been completely recovered with normalization of hepatic enzymes. Conclusion: This report provides a clinical characteristic for a severe hepatotoxicity induced by antituberculosis drugs, and showed an example of TKM-based application.

Pharmacognostic evaluation of the roots of Berberis lycium royle

  • Srivastava, Sharad Kumar;Rawat, Ajay Kumar Singh;Mehrotra, Shanta
    • Advances in Traditional Medicine
    • /
    • 제10권3호
    • /
    • pp.184-190
    • /
    • 2010
  • Berberis lycium (family Berberidaceae) has a close affinity with B. aristata, used in India Traditional Systems of Medicine as a drug 'Daruharidra' for skin disease, jaundice, affection of eyes, and rheumatism. Various species of Berberis are being sold in India herbal drug market. During the market surveillance of different herbal drug markets of India, it was observed that almost all the markets either comprise of Berberis lycium or Berberis asiatica. Keeping this in view, in the present study attempts have been made to identify marker characters of this potent species.

열약과 한약의 사기론적 평가기준에 대한 실험적 연구 (Experimental study on the standardization of the Hot and the Cold Natures)

  • 이한구;남봉현;이미영;김정숙
    • 한국한의학연구원논문집
    • /
    • 제2권1호
    • /
    • pp.506-513
    • /
    • 1996
  • The odor theory(氣味論) has been defined as the Nature(氣) and the Taste(味) of traditional herbal medicine to find the logic in treatment of various diseases by them. There is a strong possibility these Natures of the drug can be categorized according to yin(陰) and yang(陽). To understand the Hot and the Cold Natures of traditional herbal drugs in scientific approaches, changes in skin, rectal temperature of rats have been measured at 0, 30, 60, 90 min after a 5, 10, 20g/Kg oral administration each of Coptidis Rizoma(Ranunculaceae, Coptis chinesis, $F_{RANCH}$), Aconiti Lateralis Preparata Radix(Ranunculaceae, Aconitum carmichaeli $D_{EBX}$). From this study, we obtained as follows. 1. We can categorize the four Natures of drug according to yin(陰) - Cool and Cold Natures and yang(陽) - Warm and Hot Natures. 2. The relation between the four Natures of drug and the changes of body temperature can be studied as the considertion of the dosage and the preparation of crude medicines. 3. Herbs containing toxicant should be studied carefully without the side effects.

  • PDF

한방임상사용 의료기기의 실태 조사를 통한 개선방향 제시 (Actual Condition Survey and Improvement of Medical Devices in Korea Traditional Medicine)

  • 문진석;김종열;류연희;송낙근;김혁주;이정림;이재원;최선미
    • 한국한의학연구원논문집
    • /
    • 제11권1호
    • /
    • pp.119-125
    • /
    • 2005
  • We conduct a survey of actual condition of medical devices in korea traditional medicine on 157 oriental medicine doctors and 183 manufacturers. The 61% percent of doctors indicate the trouble in use of medical devices which is applied to korea traditional medicine. The manufacturers replied that devices have a problem with diagnosis(53%) and treatment(36%). To overcome these problems, it is necessary to develop devices based on the study of basic oriental medicine and the reliable clinical research. This study contributes the improvement of quality and the revision of rules on medical devices.

  • PDF